AfterRaise/Companies/EnteroBiotix

EnteroBiotix

£19M UndisclosedRaised 5 months agoUKOtherUK

In their own words

What EnteroBiotix says it is doing

Work here? Claim your company profile
Market expansionResearch and development

Public signal Read from the company's own description of what the funding supports.

Why now

Where EnteroBiotix is today

EnteroBiotix announced a funding round of £19M on 4 May 2026, led by Thairm Bio and the Scottish National Investment Bank.

Latest round
Undisclosed
Amount
£19M
Announced
4 May 2026
Headquarters
UK
Sector
Other
Growth stage
Growth
Investors
Also participating
new and existing investors
Relevant leadership
CEO Dr James McIlroy

Momentum AfterRaise intelligence

AfterRaise Score

44
Established
0 funding signals in the last 90 days
Funding recency
18/40
announced within the last 6 months
Round scale
16/25
round size relative to the market
Funding stage
10/20
Undisclosed
Funding cadence
0/15
one funding event tracked this year
Arriving with the signals layer
  • Hiring momentum Open roles and hiring pace
  • Market expansion New offices and new countries
  • Leadership Executive appointments
  • Product activity Launches and releases

Since the raise

What has happened since

  • 4 May 2026
    £19M raised
    Led by Thairm Bio and the Scottish National Investment Bank.

Public signal The timeline currently holds funding events, because those are the signals AfterRaise observes today. Hiring, leadership, expansion and product events join it with the signals layer.

What may happen next

What this raise could create

AfterRaise intelligenceNot a statement of fact

What may happen next

  • New market entry
  • First local hires in the new market
  • Local entity and legal setup
  • Research programme expansion

Opportunities this could create

  • Operations hiring
  • Go-to-market partnerships
  • Market-entry advisers
  • Local employment infrastructure
  • In-market partnerships

Based on the Other sector, a Growth round and the priorities the company itself set out. Not a statement of fact.

Early momentum3 connected signals
  • 4 May 2026£19M round announced
  • 4 May 2026Stated priority: market expansion
  • 4 May 2026Stated priority: research and development

High momentum means several meaningful company changes have occurred in a short period. Signals here are funding events and the priorities the company stated; hiring, leadership and expansion detection join with the signals layer.

Open to

What EnteroBiotix is open to

Not yet specified

EnteroBiotix has not told AfterRaise which approaches it welcomes. Until it does, we do not assume. Offers to help are held and shown to the company, and the company decides whether to open a conversation.

Work here? Set your preferences

Opportunities

Ways to work with EnteroBiotix

No open opportunities listed

Jobs, projects, partnerships, advisory and supplier needs appear here once the company has claimed its page and published them, and any role we read from its own job board appears automatically.

Work here? Open the first one

Helpful contributors

People who have contributed here

Nobody yet

When someone offers help and the company says it was useful, they appear here. Reputation on AfterRaise is built from contributions the company confirmed, not from follower counts.

Do you work at EnteroBiotix?

Claim your company profile.

This page was created from publicly available information. A verified representative corrects the record, says what the company is building next and chooses which conversations it welcomes.

What we do not have yet: your website and the roles and projects you have open. Claiming the page is how you fill those in.

Someone else requesting access does not give them ownership. Every representative is verified by a person before access is granted.

Maintaining your own company profile is free. A founder, CEO or authorised senior colleague can represent the company.

Also moving

Other Other companies

See the sector